SM-13496 (Lurasidone HCl)

lurasidone · Sumitomo Pharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SM-13496 (Lurasidone HCl), covering 2018-10-19 to 2018-10-19. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia [Phase 3]